Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study

Background/Objectives: Diabetic macular edema (DME) is a significant cause of visual impairment, often treated with anti-vascular endothelial growth factor (anti-VEGF) agents. However, some patients do not respond adequately to this treatment. This study aims to evaluate the contribution of the intr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ferhat Turgut, Gábor M. Somfai, Christoph Tappeiner, Katja Hatz, Irmela Mantel, Aude Ambresin, Guy Donati, Viviane Guignard, Dana Nagyová, Isabel B. Pfister, Christine Schild, Justus G. Garweg
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-09-01
coleção:	Pharmaceuticals
Assuntos:	diabetic macular edema intravitreal dexamethasone implant anti-VEGF
Acesso em linha:	https://www.mdpi.com/1424-8247/17/9/1235
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!